About Our Research Labels
Evidence Methodology
How RasaBridge assesses and labels research for Ayurvedic herbs — and what our labels do and do not mean.
Our Core Principles
We describe, not validate
RasaBridge describes what research exists — we do not endorse, validate, or certify any herb's efficacy or safety. Our labels reflect the volume and type of published literature, not clinical proof.
Traditional use ≠ modern evidence
Centuries of traditional use are historically significant and worth documenting. They do not substitute for modern clinical evidence. We clearly separate traditional context from research context on every herb profile.
Study quality varies widely
Many published studies on Ayurvedic herbs are small, short-term, or lack rigorous controls. A high study count does not mean strong evidence. We note this limitation explicitly and avoid overstating findings.
We do not cite individual studies
RasaBridge does not link to or endorse specific research papers. Our labels are editorial summaries of the general state of published literature. For academic use, always consult primary sources and systematic reviews.
No approval claims
Nothing on RasaBridge implies regulatory approval (FDA, CDSCO, AYUSH, or otherwise) of any herb for any condition. Where an isolated compound has pharmacological history (e.g. Reserpine), we note the compound — not the herb — has that history.
Labels are periodically reviewed
Research in this field evolves. Our labels are snapshots based on available literature at time of content creation. They may not reflect the most current scientific consensus. We update them as the platform matures.
What Each Label Means
A compound isolated from this herb has been studied in modern pharmacology or has historical significance in drug development. This does not mean the herb itself is a drug, is FDA/CDSCO approved, or is safe for self-use. Example: Reserpine from Sarpagandha.
A relatively high number of published studies exist for this herb, including some human trials. This reflects research interest, not clinical approval or proof of efficacy. Study quality varies. Example: Turmeric (Curcumin), Yashtimadhu (Licorice).
A meaningful body of published research exists, including laboratory and some human studies. Findings are preliminary to moderate. Researchers have documented consistent interest in this herb. Example: Ashwagandha, Brahmi, Tulsi.
Some published research exists with encouraging preliminary results, but human clinical data is limited. More studies are needed before strong conclusions can be drawn. Example: Shatavari, Arjuna.
Limited published research, primarily laboratory or animal studies. Human evidence is sparse or absent. Traditional use is documented but modern research is at an early stage. Example: Manjistha, Vidanga, Vacha.